Published in Biotech Law Weekly, August 26th, 2005
The patent is being secured as the basis for a new disposable device that would enable the use of simultaneous brachytherapy (interstitial radiation) and microwave hyperthermia therapy, employing BSD's existing systems. Current technology allows only sequential treatments.
According to research with a breast cancer model, when hyperthermia therapy (a thermal treatment for cancer) was administered simultaneously with radiation, the effective dose of radiation (thermal enhancement) was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.